Starling Oncology (STLN) EBITDA Margin (2021 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) EBITDA Margin (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.73 Bn | 89.71 Bn | 15.19 Bn | -12.60% |
| 2 | Tenet Healthcare | 22.05 Bn | 19.88 Bn | 4.45 Bn | 26.67% |
| 3 | Encompass Health | 12.13 Bn | 12.00 Bn | 1.34 Bn | 2.10% |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 16.29% |
| 5 | Universal Health Services | 10.12 Bn | 9.98 Bn | 3.29 Bn | 11.14% |
| 6 | Ensign | 9.97 Bn | 9.64 Bn | 306.24 Mn | 8.50% |
| 7 | Chemed | 6.91 Bn | 6.87 Bn | 221.47 Mn | 15.37% |
| 8 | Pacs | 6.73 Bn | 6.57 Bn | 338.46 Mn | 7.66% |
| 9 | Concentra Group Holdings Parent | 4.30 Bn | 4.14 Bn | 192.10 Mn | 18.99% |
| 10 | Starling Oncology | 613.55 Mn | 572.46 Mn | 27.17 Mn | -2.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.17% |
| Mar 31, 2026 | -3.81% |
| Dec 31, 2025 | -4.22% |
| Sep 30, 2025 | -5.16% |
| Jun 30, 2025 | -8.50% |
| Mar 31, 2025 | -8.52% |
| Dec 31, 2024 | -10.97% |
| Sep 30, 2024 | -13.07% |
| Jun 30, 2024 | -15.84% |
| Mar 31, 2024 | -18.23% |
| Dec 31, 2023 | -16.88% |
| Sep 30, 2023 | -15.86% |
| Jun 30, 2023 | -17.87% |
| Mar 31, 2023 | -42.43% |
| Dec 31, 2022 | -34.47% |
| Sep 30, 2022 | -30.32% |
| Jun 30, 2022 | -29.46% |
| Mar 31, 2022 | -32.92% |
| Dec 31, 2021 | -77.56% |
| Sep 30, 2021 | -3.70% |